enVVeno Medical Corp
Change company Symbol lookup
Select an option...
NVNO enVVeno Medical Corp
ST Sensata Technologies Holding PLC
ZTS Zoetis Inc
AZZ AZZ Inc
CRM Salesforce Inc
IVR-C Invesco Mortgage Capital Inc
MSM MSC Industrial Direct Co Inc
BLUE bluebird bio Inc
ENSV Enservco Corp
ULIHF United Laboratories International Holdings Ltd
Go

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

enVVeno Medical Corporation is a med-tech company. The Company is focused on improving the standard of care in the treatment of venous disease. The Company is focused on developing tissue-based solutions that are designed for patients with chronic venous insufficiency (CVI). Its lead product, VenoValve, is a porcine based device being developed to surgically implanted in the deep venous system of the leg to treat severe CVI, including the potential to heal recurring venous leg ulcers. The VenoValve is designed to be implanted into the femoral vein of the patient in an open surgical procedure via a five-to-six-inch incision in the upper thigh. The VenoValve is being evaluated in the surgical anti-reflux venous valve endoprosthesis (SAVVE) United States clinical trial. In addition to the VenoValve, the Company is focused on the development of a second device, enVVe, for the treatment of venous disease.

Postmarket

Last Trade
Delayed
$3.91
-0.205 (-4.98%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$4.12
Day's Change
0.245 (6.33%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
4.14
Day's Low
3.81
Volume
(Below Average)
Volume:
17,677

10-day average volume:
19,719
17,677

Upcoming Events

NVNO's fiscal year ends in December
There are no upcoming events for NVNO

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
April 29, 2022Q1 2022 Earnings Release-$0.47-$0.29 to -$0.29-$0.48
March 28, 2022Q4 2021 Earnings Release-$0.94-$0.33 to -$0.33-$2.46
November 12, 2021Q3 2021 Earnings Release-$0.26-$0.34 to -$0.34-$1.25
August 11, 2021Q2 Earnings Announcement------
August 11, 2021Q2 2021 Earnings Release-$0.28-$0.34 to -$0.34--

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.